FDA Adverse Event Injury Summary report: N

UKNOWN NASOGASTRIC TUBE

MDR report key: 14287915 · Received May 5, 2022

Report

Report Number
1018233-2022-03311
Event Type
Injury
Date Received
May 5, 2022
Date of Event
March 21, 2022
Report Date
July 26, 2022
Manufacturer
C.R. BARD, INC. (COVINGTON) -1018233
Product Code
BSS
PMA / PMN Number
EXEMPT
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE INVESTIGATION IS STILL IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETE A SUPPLEMENTAL REPORT WILL BE FILED. THE DEVICE WAS NOT RETURNED.

Additional Manufacturer Narrative · 0

THE REPORTED EVENT WAS INCONCLUSIVE BECAUSE NO SAMPLE WAS RETURNED. A POTENTIAL ROOT CAUSE FOR THIS FAILURE COULD BE "INCORRECT SET-UP". IT WAS UNKNOWN WHETHER THE PRODUCT HAD CAUSED THE REPORTED FAILURE. IT IS UNKNOWN WHETHER THE DEVICE HAD MET RELEVANT SPECIFICATIONS. THE PRODUCT WAS USED FOR TREATMENT PURPOSES. THE LOT NUMBER WAS UNKNOWN; THEREFORE, THE DEVICE HISTORY RECORD COULD NOT BE REVIEWED. UNABLE TO PERFORM LABELING REVIEW DUE TO UNKNOWN PRODUCT CODE. ALTHOUGH THE PRODUCT FAMILY WAS UNKNOWN, THE (UNKNOWN NG TUBE) PRODUCT IFUS WERE FOUND TO BE ADEQUATE BASED ON PAST REVIEWS. CORRECTION: G H11: SECTION A THROUGH F - THE INFORMATION PROVIDED BY BD REPRESENTS ALL THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BD. H3 OTHER TEXT : THE DEVICE WAS NOT RETURNED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE NASOGASTRIC SALEM SUMP TUBE WAS WITH NO CLEAR MARKERS FOR INSERTION MEASUREMENT. IT WAS STATED THAT ON (B)(6) 2022, THE PATIENT HAD A TRAUMA. PATIENT WAS INTUBATED AND AN OROGASTRIC WAS PLACED. THE TUBE WAS COILED IN THE STOMACH AND NEEDED TO BE PULLED BACK. THE NURSES WERE UNABLE TO TELL HOW FAR THEY PULLED THE TUBE BACK OR HOW FAR THE TUBE WAS INSERTED INTO THE PATIENT. ALSO STATED THAT IT WAS DIFFICULT TO TRACK OF HOW FAR TO INSERT THE NASOGASTRIC TUBE INTO THE PATIENT WITH NO CLEAR MARKINGS. THIS POTENTIALLY LED TO COILING IN THE STOMACH AND NEEDING TO BE PULLED BACK. ONCE PULLED BACK, THE HOSPITAL STAFF TEAM WERE ALL UNABLE TO TELL HOW FAR THE TUBE WAS INSERTED. THE CURRENT BARD NASOGASTRIC TUBE DID NOT HAVE NUMERICAL NUMBERS IT USES GENERIC MARKERS MARKED AT 18-INCH, 22-INCH, 26-INCH, AND 30-INCH FROM DISTAL TIP. THE CUSTOMER RECOMMENDED TO SWITCH TO A NASOGASTRIC TUBE THAT HAS CLEAR MARKINGS TO IDENTIFY EXACTLY THE DISTANCE THE TUBE WAS INSERTED. MEDICAL INTERVENTION WAS UNKNOWN.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE NASOGASTRIC SALEM SUMP TUBE WAS WITH NO CLEAR MARKERS FOR INSERTION MEASUREMENT. IT WAS STATED THAT ON (B)(6) 2022, THE PATIENT HAD A TRAUMA. PATIENT WAS INTUBATED AND AN OROGASTRIC WAS PLACED. THE TUBE WAS COILED IN THE STOMACH AND NEEDED TO BE PULLED BACK. THE NURSES WERE UNABLE TO TELL HOW FAR THEY PULLED THE TUBE BACK OR HOW FAR THE TUBE WAS INSERTED INTO THE PATIENT. ALSO STATED THAT IT WAS DIFFICULT TO TRACK OF HOW FAR TO INSERT THE NASOGASTRIC TUBE INTO THE PATIENT WITH NO CLEAR MARKINGS. THIS POTENTIALLY LED TO COILING IN THE STOMACH AND NEEDING TO BE PULLED BACK. ONCE PULLED BACK, THE HOSPITAL STAFF TEAM WERE ALL UNABLE TO TELL HOW FAR THE TUBE WAS INSERTED. THE CURRENT BARD NASOGASTRIC TUBE DID NOT HAVE NUMERICAL NUMBERS IT USES GENERIC MARKERS MARKED AT 18-INCH, 22-INCH, 26-INCH, AND 30-INCH FROM DISTAL TIP. THE CUSTOMER RECOMMENDED TO SWITCH TO A NASOGASTRIC TUBE THAT HAS CLEAR MARKINGS TO IDENTIFY EXACTLY THE DISTANCE THE TUBE WAS INSERTED. MEDICAL INTERVENTION WAS UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1380196 UKNOWN NASOGASTRIC TUBE UKNOWN NASOGASTRIC TUBE BSS C.R. BARD, INC. (COVINGTON) -1018233 UNK

Patients

Seq Age Sex Outcome Treatment
1 Unknown Required Intervention